You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2025

List of Excipients in API deflazacort


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing deflazacort

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
PTC Therapeutics Inc EMFLAZA deflazacort 52856-501 LACTOSE MONOHYDRATE
PTC Therapeutics Inc EMFLAZA deflazacort 52856-501 MAGNESIUM STEARATE
PTC Therapeutics Inc EMFLAZA deflazacort 52856-501 SILICON DIOXIDE
PTC Therapeutics Inc EMFLAZA deflazacort 52856-501 STARCH, PREGELATINIZED CORN
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Get Started Free

Excipients in ANDA-approved (generic) drugs containing deflazacort

Company Ingredient NDC Excipient
Upsher-Smith Laboratories LLC deflazacort 0832-0815 LACTOSE MONOHYDRATE
Upsher-Smith Laboratories LLC deflazacort 0832-0815 MAGNESIUM STEARATE
Upsher-Smith Laboratories LLC deflazacort 0832-0815 SILICON DIOXIDE
Upsher-Smith Laboratories LLC deflazacort 0832-0815 STARCH, CORN
Aurobindo Pharma Limited deflazacort 59651-599 LACTOSE MONOHYDRATE
Aurobindo Pharma Limited deflazacort 59651-599 MAGNESIUM STEARATE
Aurobindo Pharma Limited deflazacort 59651-599 POLYSORBATE 80
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Get Started Free

Detailed excipient profiles for deflazacort

Excipient focus: ACETIC ACID

Excipient focus: BENZYL ALCOHOL

Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM ALUMINUM SILICATE TYPE IC

deflazacort drug variants not containing MAGNESIUM ALUMINUM SILICATE TYPE IC

Company Ingredient NDC
Upsher-Smith Laboratories LLC deflazacort 0832-0815
PTC Therapeutics Inc deflazacort 52856-501
Aurobindo Pharma Limited deflazacort 59651-599
Sun Pharmaceutical Industries Limited deflazacort 70095-040
Zydus Pharmaceuticals (USA) Inc deflazacort 70710-1749
Zydus Pharmaceuticals (USA) Inc deflazacort 70710-2051
Aucta Pharmaceuticals Inc deflazacort 73289-0089
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: MAGNESIUM ALUMINUM SILICATE TYPE IIA

deflazacort drug variants not containing MAGNESIUM ALUMINUM SILICATE TYPE IIA

Company Ingredient NDC
Upsher-Smith Laboratories LLC deflazacort 0832-0815
PTC Therapeutics Inc deflazacort 52856-501
Aurobindo Pharma Limited deflazacort 59651-599
Sun Pharmaceutical Industries Limited deflazacort 70095-040
Zydus Pharmaceuticals (USA) Inc deflazacort 70710-1749
Zydus Pharmaceuticals (USA) Inc deflazacort 70710-2007
Zydus Pharmaceuticals (USA) Inc deflazacort 70710-2051
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: MAGNESIUM STEARATE

Excipient focus: NONCRYSTALLIZING SORBITOL SOLUTION

deflazacort drug variants not containing NONCRYSTALLIZING SORBITOL SOLUTION

Company Ingredient NDC
Upsher-Smith Laboratories LLC deflazacort 0832-0815
PTC Therapeutics Inc deflazacort 52856-501
Aurobindo Pharma Limited deflazacort 59651-599
Sun Pharmaceutical Industries Limited deflazacort 70095-040
Zydus Pharmaceuticals (USA) Inc deflazacort 70710-1749
Zydus Pharmaceuticals (USA) Inc deflazacort 70710-2007
Zydus Pharmaceuticals (USA) Inc deflazacort 70710-2051
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: POLYSORBATE 80

Excipient focus: SILICON DIOXIDE

deflazacort drug variants containing SILICON DIOXIDE

Company Ingredient NDC
Upsher-Smith Laboratories LLC deflazacort 0832-0815
PTC Therapeutics Inc deflazacort 52856-501
Aurobindo Pharma Limited deflazacort 59651-599
Sun Pharmaceutical Industries Limited deflazacort 70095-040
Zydus Pharmaceuticals (USA) Inc deflazacort 70710-1749
Zydus Pharmaceuticals (USA) Inc deflazacort 70710-2051
Aucta Pharmaceuticals Inc deflazacort 73289-0089
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: SORBITOL SOLUTION

deflazacort drug variants not containing SORBITOL SOLUTION

Company Ingredient NDC
Upsher-Smith Laboratories LLC deflazacort 0832-0815
PTC Therapeutics Inc deflazacort 52856-501
Aurobindo Pharma Limited deflazacort 59651-599
Sun Pharmaceutical Industries Limited deflazacort 70095-040
Zydus Pharmaceuticals (USA) Inc deflazacort 70710-1749
Zydus Pharmaceuticals (USA) Inc deflazacort 70710-2051
Aucta Pharmaceuticals Inc deflazacort 73289-0089
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: STARCH, CORN

Excipient focus: STARCH, PREGELATINIZED CORN

deflazacort drug variants not containing STARCH, PREGELATINIZED CORN

Company Ingredient NDC
Upsher-Smith Laboratories LLC deflazacort 0832-0815
Aurobindo Pharma Limited deflazacort 59651-599
Sun Pharmaceutical Industries Limited deflazacort 70095-040
Zydus Pharmaceuticals (USA) Inc deflazacort 70710-1749
Zydus Pharmaceuticals (USA) Inc deflazacort 70710-2007
Zydus Pharmaceuticals (USA) Inc deflazacort 70710-2051
Zydus Pharmaceuticals (USA) Inc deflazacort 70710-2131
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: WATER

deflazacort drug variants not containing WATER

Company Ingredient NDC
Upsher-Smith Laboratories LLC deflazacort 0832-0815
PTC Therapeutics Inc deflazacort 52856-501
Aurobindo Pharma Limited deflazacort 59651-599
Sun Pharmaceutical Industries Limited deflazacort 70095-040
Zydus Pharmaceuticals (USA) Inc deflazacort 70710-1749
Zydus Pharmaceuticals (USA) Inc deflazacort 70710-2007
Zydus Pharmaceuticals (USA) Inc deflazacort 70710-2051
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links